Hong Kong Stock Market Surges | Eucon Biotech-B (01477.HK) rises over 7% in the morning with the approval of the registration application for OT-502 new drug for postoperative inflammation in ophthalmology.

According to the wisdom finance app, Eucon Pharmaceuticals-B (01477.HK) surged over 7% in the morning session, with a rise of 7.45% as of press time, reaching 5.05 Hong Kong dollars, with a trading volume of 6.3473 million Hong Kong dollars.